Soligenix Inc Sustainability Reports
Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300MN2EF9LQHLT817
FIGI: BBG001SBZ0D9
5 reports from 2011 to 2024